ICAP Clinical Trials Unit for HIV Prevention at Columbia University
Official title: ICAP Clinical Trials Unit
Funded at Columbia University Health Sciences · NIH-11579234 · Data updated 2026-11-12
A program supporting HIV prevention research across multiple sites to help people at risk access better prevention options and care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | December 1, 2020 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $46,930 |
| NIH project number | 3UM1AI154468-06S1 |
| Project ID | NIH-11579234 on NIH RePORTER |
Who could benefit from this research
✓Could help
People at high risk for HIV who participate in prevention trials or use included prevention tools and services through clinical research sites.
✕Less likely to help
Individuals not connected to the clinical research sites or not eligible for the included prevention studies may see limited direct benefit.
What this research studies
This grant funds the ICAP Clinical Trials Unit at Columbia University to coordinate HIV prevention research across affiliated sites serving high-risk populations. It aims to advance the NIH HIV Prevention Trials Network agenda, strengthen administrative and operational systems, and ensure high-quality data, regulatory, and laboratory support. The unit emphasizes community engagement, education, and ongoing staff development to improve prevention tools and services for people at risk for HIV. By creating a cohesive, efficient, and transparent research unit, the program seeks to translate prevention science into real-world impact for communities most affected by HIV.
Why it matters
Potential benefit: If successful, the program could accelerate effective HIV prevention strategies and improve access to prevention services for people at risk.
How similar studies have gone: Similar CTU models have improved trial efficiency and community engagement in HIV prevention research, with established networks showing positive outcomes.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: El-Sadr, Wafaa M. — Columbia University Health Sciences
- Study coordinator: El-Sadr, Wafaa M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.